News | September 04, 2024
Siegfried opens quality control lab in Minden
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
Mirabegron Extended-Release Tablets, 50 mg is a generic equivalent of Myrbetriq® Extended-Release Tablets, 50 mg of Astellas Pharma Global Development
ForDoz Pharma Corporation, USA (ForDoz) received an approval for its ANDA from the USFDA
The approval further adds to Biocon’s portfolio of complex drug products
TABRECTA is the brand of Novartis. Natco believes it is the first company to have filed a substantially-complete ANDA
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
Brimonidine Tartrate Ophthalmic Solution, 0.1% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Also received tentative approval for 137 mg
Subscribe To Our Newsletter & Stay Updated
